Concourse Financial Group Securities’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,173
Closed -$27.7K 1650
2024
Q4
$27.7K Sell
1,173
-2
-0.2% -$51 ﹤0.01% 1445
2024
Q3
$29.3K Sell
1,175
-128
-10% -$3.79K ﹤0.01% 1398
2024
Q2
$38.6K Buy
1,303
+311
+31% +$8.63K ﹤0.01% 1287
2024
Q1
$29.9K Sell
992
-600
-38% -$16.6K ﹤0.01% 1384
2023
Q4
$45.5K Sell
1,592
-5,385
-77% -$158K ﹤0.01% 1164
2023
Q3
$258K Sell
6,977
-19
-0.3% -$726 0.02% 550
2023
Q2
$273K Buy
6,996
+6,128
+706% +$240K 0.02% 563
2023
Q1
$31.7K Buy
868
+86
+11% +$2.71K ﹤0.01% 1279
2022
Q4
$24.1K Buy
+782
New +$24.3K ﹤0.01% 1401

Other funds holding RTO

Concourse Financial Group Securities's RTO Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Rentokil (RTO) in Q1 2025, closing a stake of 1,173 shares — an estimated $27.7K sold.

Concourse Financial Group Securities first reported a position in RTO in Q4 2022 and held it in 9 quarters. The position peaked at $273K in Q2 2023. 210 funds tracked by Wall St. Rank hold RTO as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Rentokil position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,173 Rentokil shares in Q1 2025, an estimated $27.7K.
  • Concourse Financial Group Securities first reported a position in Rentokil in Q4 2022 and held it in 9 quarters.
  • Concourse Financial Group Securities's Rentokil position peaked at $273K in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Rentokil as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.